Founded in 2007, Y-Biologics is a renowned biotech company in South Korea for its expertise in antibody science. Since its foundation, we have dedicated ourselves to the discovery & development of novel antibody therapeutics. By utilizing our two platform technologies Y-max ABLTM & ALiCETM in R&D process, we aim to be a leading biopharmaceutical company in fields of immuno-oncology.
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.